Testing the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia

NCT06979778 | Not Yet Recruiting

• 1 other identifier: 20250512
• Study Type: interventional
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn if using the "See Yourself Differently" (syd) app can help improve quality of life and mental health for university students in Saudi Arabia. The study also aims to see if the app can help lower anxiety and stress, and increase positive feelings while decreasing negative feelings. The main questions it aims to answer are:

1. 1.Does the "syd" app improve the quality of life for university students?
2. 2.Does the "syd" app help lower anxiety and stress in university students
3. 3.Does the "syd" app help increase positive feelings and decrease negative feelings in university students?
4. 4.Use the "syd" app for 3 months.
5. 5.Complete surveys about their quality of life, anxiety, stress, and feelings.

Conditions

Quality of Life (QOL); Anxiety; Stress; Affect (Mental Function)

Keywords

syd; QoL; See Yourself Differently; Quality of Life; mHealth; App; RCT

Outcome Measures

Primary Outcomes (1)

• Change in Quality of Life Domain Scores

  Quality of Life (QoL) as measured through the WHOQOL-BREF instrument. The WHOQOL-BREF is a 26-item questionnaire which uses a scoring system that assesses quality of life across four domains: physical health, psychological health, social relationships, and environmental health. Each item is scored on a 5-point scale (1-5) and transformed to a 0-100 scale. Domain scores are calculated by summing relevant item scores and transforming them to a 0-100 scale. Higher scores indicate better quality of life in a specific domain.

  From enrolment to the end of treatment at 3 months

Secondary Outcomes (3)

• Change in Anxiety Score

  From enrolment to the end of treatment at 3 months

• Change in Perceived Stress Score

  From enrolment to the end of treatment at 3 months

• Change in Positive and Negative Affect Scores

  From enrolment to the end of treatment at 3 months

Study Arms (2)

syd app

EXPERIMENTAL

The 'syd' application is designed as an AI-powered "Life Quality Mentor" with the primary aim of enhancing users' quality of life. The app focuses on positive habit development, personalised feedback, and continuous support. It offers personalised guidance across various domains, including Physical health, Emotional health, Brain power, Self-awareness, Purpose, Career, Financial health, Social life and Environment. It utilizes an advanced AI platform and offers features like personalised recommendations, supportive interaction with an AI mentor, habit tracking tools, and integration with wearable technology. The intervention arm will have full access to the 'syd' app and be able to interact with it for the 3 months duration of the trial

Device: See Yourself Differently (syd) mobile app

Wait list control

NO INTERVENTION

The wait list control arm will not receive access to the 'syd' app for the 3 months' duration of the trial, but will be given full lifetime access thereafter.

Interventions

See Yourself Differently (syd) mobile app DEVICE

The 'syd' mobile app is designed as an AI-powered "Life Quality Mentor" with the primary aim of enhancing users' quality of life. The app focuses on positive habit development, personalised feedback, and continuous support. It offers personalised guidance across various domains, including Physical health, Emotional health, Brain power, Self-awareness, Purpose, Career, Financial health, Social life and Environment. It utilizes an advanced AI platform and offers features like personalised recommendations, supportive interaction with an AI mentor, habit tracking tools, and integration with wearable technology.

Also known as: syd, See Yourself Differently

syd app

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age ≥ 18 years.
• Enrolled as a full-time medical student at the Alfaisal university.
• Owning a smartphone (iOS or Android) compatible with the "syd" app.
• Willing to provide informed consent and comply with study procedures

You may not qualify if:

• Known severe psychiatric or cognitive conditions that impede app usage
• Inability to provide informed consent

Sponsors & Collaborators

• iamYiam Limited: lead
• Alfaisal University: collaborator

Study Sites (1)

Alfaisal University

Riyadh, 11533, Saudi Arabia

Location

MeSH Terms

Conditions

Anxiety Disorders; Alzheimer Disease

Condition Hierarchy (Ancestors)

Mental Disorders; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders

Study Officials

• Ahmed Abu-Zaid, MD

  Alfaisal University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Pedro M Henriques, PhD

CONTACT

+351928091841; pedro.henriques@syd.life

Lorena Puica

CONTACT

lorena@syd.life

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 12, 2025
• First Posted: May 20, 2025
• Study Start: May 1, 2025
• Primary Completion: August 1, 2025
• Study Completion: August 1, 2025
• Last Updated: May 23, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

SA (1)